BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12887719)

  • 1. Low-density lipoprotein apheresis: an overview.
    Bambauer R; Schiel R; Latza R
    Ther Apher Dial; 2003 Aug; 7(4):382-90. PubMed ID: 12887719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low density lipoprotein apheresis in treatment of hyperlipidemia: experience with four different technologies.
    Bambauer R; Schiel R; Latza R
    Ther Apher; 2000 Jun; 4(3):213-7. PubMed ID: 10910023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoprotein apheresis: clinical results with different methods.
    Bambauer R
    Artif Organs; 2002 Feb; 26(2):133-9. PubMed ID: 11879241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LDL-apheresis as long-term treatment in severe hyperlipidemia using differing methods.
    Bambauer R; Schiel R; Latza R; Schneidewind JM
    ASAIO J; 1999; 45(5):408-12. PubMed ID: 10503616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current topics on low-density lipoprotein apheresis.
    Bambauer R; Schiel R; Latza R
    Ther Apher; 2001 Aug; 5(4):293-300. PubMed ID: 11724515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LDL apheresis in clinical practice: long-term treatment of severe hyperlipidemia.
    Bambauer R; Schiel R; Latza R; Klinkmann J; Schneidewind JM
    Ther Apher; 1997 Feb; 1(1):49-54. PubMed ID: 10225781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of severe hyperlipidemia: six years' experience with low-density lipoprotein apheresis.
    Bambauer R; Schiel R; Latza R; Klinkmann J
    Artif Organs; 1996 Apr; 20(4):336-9. PubMed ID: 9139620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LDL-apheresis: technical and clinical aspects.
    Bambauer R; Bambauer C; Lehmann B; Latza R; Schiel R
    ScientificWorldJournal; 2012; 2012():314283. PubMed ID: 22654591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein apheresis in the treatment of two patients with coronary heart disease and extremely elevated lipoprotein (a) levels.
    Bambauer R; Schiel R; Keller HE; Klinkmann J; Latza R
    Artif Organs; 1996 Apr; 20(4):340-3. PubMed ID: 9139621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
    Lee WP; Datta BN; Ong BB; Rees A; Halcox J
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein apheresis for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Olbricht CJ; Schoeppe E
    Ther Apher; 1997 Aug; 1(3):242-8. PubMed ID: 10225746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDL-apheresis in two patients with extremely elevated lipoprotein (a) levels.
    Bambauer R; Schiel R; Keller HE; Latza R
    Int J Artif Organs; 1995 May; 18(5):286-90. PubMed ID: 8567105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effect of low-density lipoprotein apheresis in patients with heterozygous familial hypercholesterolemia.
    Higashikata T; Mabuchi H
    Ther Apher Dial; 2003 Aug; 7(4):402-7. PubMed ID: 12887722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
    Richter WO; Donner MG; Höfling B; Schwandt P
    Metabolism; 1998 Jul; 47(7):863-8. PubMed ID: 9667236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of homozygous familial hypercholesterolemia with low density lipoprotein apheresis: a 4 year follow-up study.
    Fadul JE; Vessby B; Wikström B; Danielson BG
    Artif Organs; 1997 May; 21(5):364-8. PubMed ID: 9129767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Schneidewind JM; Latza R
    ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL-apheresis in treatment of two patients with heterozygous familial hypercholesterolemia and extremely elevated lipoprotein (a) levels.
    Bambauer R; Schiel R; Latzo R; Klinkmann J
    Transfus Sci; 1995 Dec; 16(4):375-81. PubMed ID: 10159508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia.
    Makino H; Harada-Shiba M
    Ther Apher Dial; 2003 Aug; 7(4):397-401. PubMed ID: 12887721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective comparison of 5 different methods for long-term LDL-apheresis in 20 patients between 1986 and 2001.
    Krebs A; Krebs K; Keller F
    Int J Artif Organs; 2004 Feb; 27(2):137-48. PubMed ID: 15061475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.